|
| Status |
Public on Nov 04, 2022 |
| Title |
INF001R_DMSO |
| Sample type |
SRA |
| |
|
| Source name |
Bone Marrow
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: Bone Marrow
cell type: Leukemia
treatment: DMSO (control)
|
| Treatment protocol |
Cells were exposed to bortezomib or DMSO for 20 hours
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Trizol extraction
RNA sequencing was performed according to the manufacturer's instructions using the Illumina TrueSeq total stranded RNA kit.
|
| |
|
| Library strategy |
RNA-Seq |
| Library source |
transcriptomic |
| Library selection |
cDNA |
| Instrument model |
Illumina HiSeq 2000 |
| |
|
| Description |
INF001R_DMSO
|
| Data processing |
Nextflow (nf-core v 2.3, nextflow v22.02.1-edge) was used to perform QC, align FASTQ files to reference genome using "star_rsem" aligner and generate counts.
Assembly: hg38
Supplementary files format and content: tab-delimited gene counts include RPKM values for each Sample
|
| |
|
| Submission date |
Nov 03, 2022 |
| Last update date |
Nov 29, 2022 |
| Contact name |
Tanja A Gruber |
| E-mail(s) |
[email protected]
|
| Organization name |
Stanford University
|
| Department |
Pediatrics
|
| Street address |
1000 Welch Road Suite 300
|
| City |
Palo Alto |
| State/province |
CA |
| ZIP/Postal code |
94304 |
| Country |
USA |
| |
|
| Platform ID |
GPL11154 |
| Series (1) |
| GSE152816 |
Proteasome Inhibition Targets the KMT2A Transcriptional Complex |
|
| Relations |
| BioSample |
SAMN31581112 |
| SRA |
SRX18154491 |
